PET scan metabolic activity and programmed cell death-ligand 1 expression in lung cancer patients: Is there a correlation?

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. e21199-e21199
Author(s):  
Heather Katz ◽  
Raj Singh ◽  
Hayden Ansinelli ◽  
Christopher Blackwell ◽  
Mohamed Farouq Alsharedi
Keyword(s):  
Lung Cancer ◽  
Cell Death ◽  
Programmed Cell Death ◽  
Cancer Patients ◽  
Metabolic Activity ◽  
Pet Scan ◽  
Lung Cancer Patients

scholarly journals Poor efficacy of anti‐programmed cell death‐1/ligand 1 monotherapy for non‐small cell lung cancer patients with active brain metastases

2020 ◽  
Vol 11 (9) ◽  
pp. 2465-2472
Author(s):  
Takehiro Tozuka ◽  
Satoru Kitazono ◽  
Hiroaki Sakamoto ◽  
Hiroshi Yoshida ◽  
Yoshiaki Amino ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cell Death ◽  
Programmed Cell Death ◽  
Brain Metastases ◽  
Cancer Patients ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Programmed Cell Death 1 ◽  
Poor Efficacy

scholarly journals The overall safety evaluation of programmed cell death/programmed cell death ligand 1 (PD-1/PD-L1) treatment for lung cancer patients

Medicine ◽  
2019 ◽  
Vol 98 (30) ◽  
pp. e16439 ◽  
Author(s):  
Heli Shang ◽  
Zewen Zhang ◽  
Alei Feng ◽  
Xiaowei Yang ◽  
Shuisheng Zhang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cell Death ◽  
Programmed Cell Death ◽  
Cancer Patients ◽  
Safety Evaluation ◽  
Lung Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document